Literature DB >> 21411354

Association of the HLA-DRB1 locus with syphilis in a Chinese population.

Hong-Wei Jiang1, Hong-Qing Tian, Hong Liu, Na Li, Yi Zhao, Fu-Ren Zhang.   

Abstract

BACKGROUND: Syphilis is a sexually transmitted infection (STI) caused by the Treponema pallidum subspecies pallidum spirochete bacterium. The association of human leukocyte antigen (HLA) with syphilis has been reported in several populations, but not in the Chinese population. Furthermore, serology methods have mostly been used in previous studies investigating the association between STIs and HLA alleles. The objective of this study was to analyze the association of the HLA-DRB1 alleles and susceptibility to syphilis in the Chinese population.
METHODS: A polymerase chain reaction with sequence-specific primers (PCR-SSP) method was used to genotype HLA-DRB1 alleles in 196 syphilis patients and 500 healthy controls.
RESULTS: The HLA-DRB1*14 allele was more prevalent in syphilis patients than in the healthy controls (p=0.013; corrected p<0.05).
CONCLUSIONS: The allele HLA-DRB1*14 was found to be associated with susceptibility to syphilis in the Chinese population.
Copyright © 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411354     DOI: 10.1016/j.ijid.2011.01.008

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  2 in total

1.  Toll-like receptor polymorphisms are associated with increased neurosyphilis risk.

Authors:  Christina M Marra; Sharon K Sahi; Lauren C Tantalo; Emily L Ho; Shelia B Dunaway; Trudy Jones; Thomas R Hawn
Journal:  Sex Transm Dis       Date:  2014-07       Impact factor: 2.830

2.  Semen quality is affected by HLA class I alleles together with sexually transmitted diseases.

Authors:  P I Marques; J C Gonçalves; C Monteiro; B Cavadas; L Nagirnaja; N Barros; A Barros; F Carvalho; A M Lopes; S Seixas
Journal:  Andrology       Date:  2019-04-19       Impact factor: 3.842

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.